Business
MYCR: Record Q1 sales and EBIT, revised guidance, and strategic acquisitions amid rising uncertainty
MYCR: Record Q1 sales and EBIT, revised guidance, and strategic acquisitions amid rising uncertainty
About this update from Mycronic Ab
Q1 delivered record sales and EBIT, driven by strong Pattern Generators and High Volume performance, while High Flex lagged. Guidance was revised to SEK 7–7.5 billion due to tariff and currency uncertainty, with new acquisitions and expansion in Southeast Asia supporting future growth.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.